ZNO 0.00% 2.8¢ zoono group limited

Revelent section AFRSimilar to Uscom, small cap biotech stock...

  1. 21,293 Posts.
    lightbulb Created with Sketch. 1232
    Revelent section AFR

    Similar to Uscom, small cap biotech stock Zoono has also benefited from the coronavirus, with its share price jumping 102 per cent in February. On Friday its shares leapt 17 per cent to $1.90 after its surface sanitation product called the Z-71 Microbe Shield proved to be 99.99 per cent effective against the coronavirus.

    Rather than being a traditional chemical disinfectant, the shield is an "anti-microbial coating" that disrupts the structure of a virus to kill it, rather than poisoning or dehydrating it as do chemicals.

    Zoono's product was tested on the "feline coronavirus", a globally accepted surrogate that's safer to have in a standard lab environment and which has the same structure as COVID-19.

    The company had its biggest day of sales ever on Friday, bringing in $143,000 in a day.

    "A lot of globally large players have been waiting for the results, so we expect to be very busy in the next six months in both business-to-consumer and business-to-business markets," Zoono chief executive Paul Hyslop said. "We have a lot of large companies, including some government departments, approaching us for mass bulk supply."

    "We were [already] getting very busy anyway due to our work we have been undertaking in animal health, mainly pig and poultry - our product is also effective against African Swine Fever and salmonella."

 
watchlist Created with Sketch. Add ZNO (ASX) to my watchlist
(20min delay)
Last
2.8¢
Change
0.000(0.00%)
Mkt cap ! $9.889M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 180053 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 337693 1
View Market Depth
Last trade - 11.40am 16/08/2024 (20 minute delay) ?
ZNO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.